Fovea pharmaceuticals Drugs for Ocular Diseases

skip to content

Highlight

• January 7, 2008

Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa

 read more

• December 12, 2007

Fovea Pharmaceuticals Completes EUR30M Series B Financing Top venture syndicate invests to advance expanding pipeline of products to treat ophthalmic diseases

 read more

Focus
Fovea's Technology Platform
From identification of putative targets and leads, to translation into clinical trials, Fovea Pharmaceuticals technology platform:
Unique High Content Screening

Agenda

• March 17-20, 2008

COWEN’S 28th Annual Health Care Conference
Boston Marriott Copley Place – BOSTON
Corporate presentation: March 18th, 2008 at 1:30 pm

• April 7-9, 2008

BIOEUROPE SPRING
Palacio Municipal de Congresos– MADRID
Corporate presentation
Panel discussion with Bernard Gilly’s participation:
"The Secret Life of CEOs" – April 7 2008 at 5:15 pm

• May 5-7, 2008

EUROBIOTECH Forum
Hotel Arts - BARCELONA
Corporate Presentation: May 6, 2008

• May 19-20, 2008

RODMAN & RENSHAW
5th Annual Global Healthcare Conference

Le Meridien Beach Plaza Hotel Monte Carlo – MONACO

• May 28-29, 2008

BIOEQUITY EUROPE
Krasnapolsky Hotel – AMSTERDAM
Corporate presentation

• June 17-20, 2008

BIO 2008
SAN DIEGO